Kyle A. Murphy

761 total citations
9 papers, 570 citations indexed

About

Kyle A. Murphy is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Kyle A. Murphy has authored 9 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Kyle A. Murphy's work include Retinoids in leukemia and cellular processes (5 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Estrogen and related hormone effects (2 papers). Kyle A. Murphy is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Estrogen and related hormone effects (2 papers). Kyle A. Murphy collaborates with scholars based in United States, Australia and Macao. Kyle A. Murphy's co-authors include Caren M. Villano, Lori A. White, L.A. White, Leonard White, Ruth Dorn, Loredana Quadro, Xiaoyan Wang, Enqin Li, Yan Li and Ren‐He Xu and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Pharmacology and Stem Cells.

In The Last Decade

Kyle A. Murphy

9 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle A. Murphy United States 8 280 131 101 98 84 9 570
Fanny L. Casado Peru 16 278 1.0× 112 0.9× 114 1.1× 34 0.3× 93 1.1× 32 789
Fei Zou China 10 310 1.1× 101 0.8× 29 0.3× 41 0.4× 148 1.8× 18 551
Federica Ferri France 11 295 1.1× 66 0.5× 31 0.3× 50 0.5× 56 0.7× 14 572
Laura Tatangelo Italy 12 515 1.8× 67 0.5× 32 0.3× 55 0.6× 100 1.2× 13 782
Ernesto Soto‐Reyes Mexico 17 623 2.2× 220 1.7× 46 0.5× 37 0.4× 123 1.5× 41 915
Virginia Medda Italy 11 146 0.5× 138 1.1× 28 0.3× 46 0.5× 83 1.0× 12 429
Maria Mastrogiannaki France 8 220 0.8× 193 1.5× 38 0.4× 70 0.7× 36 0.4× 8 912
Elizabeth Siebert United States 12 163 0.6× 60 0.5× 20 0.2× 89 0.9× 91 1.1× 14 492
Angela Goytain Canada 14 345 1.2× 48 0.4× 42 0.4× 50 0.5× 144 1.7× 18 1.0k
Seungwoon Seo South Korea 13 583 2.1× 102 0.8× 25 0.2× 126 1.3× 129 1.5× 18 875

Countries citing papers authored by Kyle A. Murphy

Since Specialization
Citations

This map shows the geographic impact of Kyle A. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle A. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle A. Murphy more than expected).

Fields of papers citing papers by Kyle A. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle A. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle A. Murphy. The network helps show where Kyle A. Murphy may publish in the future.

Co-authorship network of co-authors of Kyle A. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle A. Murphy. A scholar is included among the top collaborators of Kyle A. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle A. Murphy. Kyle A. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jiang, Bin, Yan Li, Xiaoyan Wang, et al.. (2018). Concise Review: Mesenchymal Stem Cells Derived from Human Pluripotent Cells, an Unlimited and Quality-Controllable Source for Therapeutic Applications. Stem Cells. 37(5). 572–581. 80 indexed citations
2.
Miletti-González, Karl E., Kyle A. Murphy, Roman Wernyj, et al.. (2012). Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD). Journal of Biological Chemistry. 287(23). 18995–19007. 106 indexed citations
3.
Murphy, Kyle A.. (2008). Regulation of matrix metalloproteinase expression and activity by the aryl hydrocarbon receptor in A2058 human melanoma cells. Rutgers University Community Repository (Rutgers University). 1 indexed citations
4.
Murphy, Kyle A., et al.. (2008). The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochemical Pharmacology. 77(4). 536–546. 75 indexed citations
5.
Murphy, Kyle A., Loredana Quadro, & Lori A. White. (2007). The Intersection Between the Aryl Hydrocarbon Receptor (AhR)‐ and Retinoic Acid‐Signaling Pathways. Vitamins and hormones. 75. 33–67. 52 indexed citations
6.
Hillegass, Jedd, Kyle A. Murphy, Caren M. Villano, & Lori A. White. (2006). The impact of aryl hydrocarbon receptor signaling on matrix metabolism: implications for development and disease. Biological Chemistry. 387(9). 1159–73. 36 indexed citations
7.
Villano, Caren M., et al.. (2005). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicology and Applied Pharmacology. 210(3). 212–224. 82 indexed citations
8.
Murphy, Kyle A., Caren M. Villano, Ruth Dorn, & Lori A. White. (2004). Interaction between the Aryl Hydrocarbon Receptor and Retinoic Acid Pathways Increases Matrix Metalloproteinase-1 Expression in Keratinocytes. Journal of Biological Chemistry. 279(24). 25284–25293. 76 indexed citations
9.
Murphy, Kyle A., et al.. (1995). The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells.. PubMed. 11(4). 691–700. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026